TY  - GEN 
AU  - De Miguel Pérez, Diego
AU  - Serrano Fernández, María José
PY  - 2022
UR  - http://hdl.handle.net/10481/75680
AB  - Background: Immune-checkpoint inhibitors (ICIs) changed the therapeutic landscape of patients with lung cancer.
However, only a subset of them derived clinical benefit and evidenced the need to identify reliable predictive biomarkers.
Liquid biopsy...
LA  - eng
PB  - BMC
KW  - Extracellular vesicles
KW  - PD-L1
KW  - Biomarkers
KW  - Immunotherapy
KW  - NSCLC
TI  - Extracellular vesicle PD‑L1 dynamics predict durable response to immune‑checkpoint inhibitors and survival in patients with non‑small cell lung cancer
DO  - 10.1186/s13046-022-02379-1
ER  -